Randomized, double-blind, comparative study of dexrabeprazole 10 mg versus rabeprazole 20 mg in the treatment of gastroesophageal reflux disease.
about
Normal and polar-organic-phase high-performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro-methylated cellulose-based chiral stationary phase and determination of dexrabeprazolThe chiral bioconversion and preclinical pharmacokinetic analysis of (R)-(+)-rabeprazole in beagle dogs by HPLC and HPLC-MS/MS.Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safetyStereoselective disposition of proton pump inhibitors.Insights into the future of gastric acid suppression.Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.Acid peptic diseases: pharmacological approach to treatment.Novel anti-Helicobacter pylori therapies.Ten mg dexrabeprazole daily is as effective as 20 mg dexrabeprazole daily.Is the required therapeutic effect always achieved by racemic switch of proton-pump inhibitors?Determination of rabeprazole enantiomers in commercial tablets using immobilized cellulose-based stationary phase.Determination of rabeprazole enantiomers in dog plasma by supercritical fluid chromatography tandem mass spectrometry and its application to a pharmacokinetic study.Efficacy of S-Pantoprazole 20 mg Compared with Pantoprazole 40 mg in the Treatment of Reflux Esophagitis: A Randomized, Double-Blind Comparative Trial
P2860
Q34686617-BE85B27A-460A-424D-A034-620EEF695B05Q34736757-0DD24D42-9839-4F20-BD50-431227C1F06EQ35167717-E8E0DE34-8881-407B-B3E7-126946838A48Q37136970-2A2A0AB7-F4C9-4A50-94E0-40C9359520CDQ37588492-F52D592C-62C1-4741-8333-FDCD1BFF82E8Q37871345-DC5F202D-CA9C-4B57-B43B-DFB72AA3172BQ37913063-E66D6254-9FBC-431F-808D-C6239DDA27E2Q38257748-E6832099-E568-4EBA-ADF6-B9DB6CF7DB08Q42577374-79371CEE-FA24-46F9-BF42-04ED1DC6108CQ42936143-C3591C6A-1727-41E8-9698-4851A484A61CQ48204742-D1B7A747-B7C1-4198-AD84-2A76F9D7B4CDQ51251554-FBC6F8D9-7D16-457B-BA7C-368D462771CBQ57728317-3EAD4446-4DAF-4802-9BEA-34FC563D0126
P2860
Randomized, double-blind, comparative study of dexrabeprazole 10 mg versus rabeprazole 20 mg in the treatment of gastroesophageal reflux disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Randomized, double-blind, comp ...... stroesophageal reflux disease.
@ast
Randomized, double-blind, comp ...... stroesophageal reflux disease.
@en
Randomized, double-blind, comp ...... stroesophageal reflux disease.
@nl
type
label
Randomized, double-blind, comp ...... stroesophageal reflux disease.
@ast
Randomized, double-blind, comp ...... stroesophageal reflux disease.
@en
Randomized, double-blind, comp ...... stroesophageal reflux disease.
@nl
prefLabel
Randomized, double-blind, comp ...... stroesophageal reflux disease.
@ast
Randomized, double-blind, comp ...... stroesophageal reflux disease.
@en
Randomized, double-blind, comp ...... stroesophageal reflux disease.
@nl
P2860
P356
P1476
Randomized, double-blind, comp ...... stroesophageal reflux disease.
@en
P2093
P2860
P304
P356
10.3748/WJG.V13.I30.4100
P407
P577
2007-08-01T00:00:00Z